Message: | GPCRs are currently among the most extensively investigated drug targets in pharmaceutical industry (30-40% of actual drugs in the market). To accelerate and simplify drug discovery and development in this area, Creative Biolabs now offers a comprehensive portfolio of over 100 GPCR stable cell lines specifically engineered for function profiling of various GPCRs. Based on a unique biosensor technique, these cell lines can help to characterize compounds' in vitro function potential during early stage. Currently, we highly recommend the Magic™ GLP1R cell line to our customers around the world. https://www.creative-biolabs.com/drug-discovery/therapeutics/magic-glp1r-stable-cell-line.htm. |